State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guang Zhou, China.
Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
BMJ Open. 2020 Nov 10;10(11):e037150. doi: 10.1136/bmjopen-2020-037150.
Geographical disparities have been identified as a specific barrier to cancer screening and a cause of worse outcomes for patients with cancer. In the present study, our aim was to assess the influence of geographical disparities on the survival outcomes of patients with nasopharyngeal carcinoma (NPC) treated with intensity-modulated radiation therapy (IMRT).
Cohort study.
Guangzhou, China.
A total of 1002 adult patients with NPC (724 males and 278 females) who were classified by area of residence (rural or urban) received IMRT from 1 January 2010 to 31 December 2014, at Sun Yat-sen University Cancer Center. Following propensity score matching (PSM), 812 patients remained in the analysis.
We used PSM to reduce the bias of variables associated with treatment effects and outcome prediction. Survival outcomes were estimated using the Kaplan-Meier method and compared by the log-rank test. Multivariate Cox regression was used to identify independent prognostic factors.
In the matched cohort, 812 patients remained in the analysis. Kaplan-Meier survival analysis revealed that the rural group was significantly associated with worse overall survival (OS, p<0.001), disease-free survival (DFS, p<0.001), locoregional relapse-free survival (LRRFS, p=0.003) and distant metastasis-free survival (DMFS, p<0.001). Multivariate Cox regression showed worse OS (HR=3.126; 95% CI 1.902 to 5.138; p<0.001), DFS (HR=2.579; 95% CI 1.815 to 3.665; p<0.001), LRRFS (HR=2.742; 95% CI 1.359 to 5.533; p=0.005) and DMFS (HR=2.461; 95% CI 1.574 to 3.850; p<0.001) for patients residing in rural areas.
The survival outcomes of patients with NPC who received the same standardised treatment were significantly better in urban regions than in rural regions. By analysing the geographic disparities in outcomes for NPC, we can guide the formulation of healthcare policies.
地理差异已被确定为癌症筛查的一个特殊障碍,也是癌症患者预后较差的一个原因。本研究旨在评估地理差异对接受调强放疗(IMRT)治疗的鼻咽癌(NPC)患者生存结局的影响。
队列研究。
中国广州。
共纳入 1002 例居住区域(农村或城市)为依据分类的 NPC 成年患者(724 例男性,278 例女性),他们于 2010 年 1 月 1 日至 2014 年 12 月 31 日在中山大学肿瘤防治中心接受 IMRT。采用倾向评分匹配(PSM)后,812 例患者进入分析。
采用 PSM 减少与治疗效果和预后预测相关的变量的偏倚。采用 Kaplan-Meier 法估计生存结果,并采用对数秩检验进行比较。多变量 Cox 回归用于识别独立的预后因素。
在匹配队列中,812 例患者进入分析。Kaplan-Meier 生存分析显示,农村组的总生存(OS)(p<0.001)、无病生存(DFS)(p<0.001)、局部区域无复发生存(LRRFS)(p=0.003)和远处无转移生存(DMFS)(p<0.001)显著较差。多变量 Cox 回归显示,农村组的 OS(HR=3.126;95%CI 1.902 至 5.138;p<0.001)、DFS(HR=2.579;95%CI 1.815 至 3.665;p<0.001)、LRRFS(HR=2.742;95%CI 1.359 至 5.533;p=0.005)和 DMFS(HR=2.461;95%CI 1.574 至 3.850;p<0.001)显著更差。
接受相同标准化治疗的 NPC 患者,城市地区的生存结局显著优于农村地区。通过分析 NPC 患者结局的地理差异,我们可以指导医疗保健政策的制定。